Cargando…
Enhanced Antitumor Immune Response in 2′-5′ Oligoadenylate Synthetase-Like 1- (OASL1-) Deficient Mice upon Cisplatin Chemotherapy and Radiotherapy
Type I interferon (IFN-I) plays a critical role in the antitumor immune response. In our previous study, we showed that IFN-I-inducible 2′-5′ oligoadenylate synthetase-like 1 (OASL1) negatively regulated IFN-I production upon tumor challenge similar to that of viral infection. Thus, OASL1-deficient...
Autores principales: | Sim, Chan Kyu, Lee, Jung Hoon, Baek, In-Jeoung, Lee, Sang-Wook, Lee, Myeong Sup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462330/ https://www.ncbi.nlm.nih.gov/pubmed/31049360 http://dx.doi.org/10.1155/2019/7596786 |
Ejemplares similares
-
2′–5′ oligoadenylate synthetase‑like 1 (OASL1) protects against atherosclerosis by maintaining endothelial nitric oxide synthase mRNA stability
por: Kim, Tae Kyeong, et al.
Publicado: (2022) -
Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases
por: Choi, Un Yung, et al.
Publicado: (2015) -
Origin and development of oligoadenylate synthetase immune system
por: Hu, Jiaxiang, et al.
Publicado: (2018) -
2′‐5′ oligoadenylate synthetase 1 polymorphism is associated with prostate cancer
por: Mandal, Sanjay, et al.
Publicado: (2011) -
OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type I interferon production
por: Oh, Ji Eun, et al.
Publicado: (2016)